Tag: #cancer

NHS England rolls out 60-second pembrolizumab injection to cut treatment chair time

NHS England is introducing a subcutaneous form of pembrolizumab (Keytruda) that can be given in about a minute, reducing clinic time for roughly 14,000 patients.

#nhs, #pembrolizumab, #cancer, #immunotherapy

Brazil's new cancer framework promises free advanced therapies through SUS and a push for domestic production

Brazil approved a framework to expand free access to advanced cancer therapies via SUS, speed regulatory reviews and favor domestic production.

#brazil, #healthcare, #cancer, #anvisa